EDTA-saline and ABO system antibodies

Reactivity of FDA-approved anti-D reagents with partial D red blood cells.

Immunohematology·2006

On a much higher than reported incidence of anti-c in R1R1 patients with anti-E.

Immunohematology·2005

The gel test: use in the identification of unexpected antibodies to blood group antigens.

Immunohematology·2004

PEG adsorption of autoantibodies causes loss of concomitant alloantibody.

Immunohematology·2004

Molecular defects underlying the Kell null phenotype.

The Journal of biological chemistry·2001

The first example of a paraben-dependent antibody to an Rh protein.

Transfusion·2001

Confirmatory testing of military blood donors screening positive for Babesia infection.

Transfusion·2026

A global survey of blood transfusion practices for patients with sickle cell disease.

Transfusion·2026

Normal thromboelastography with a markedly prolonged activated partial thromboplastin time in severe prekallikrein deficiency: Implications for perioperative hemostatic assessment.

Transfusion·2026

Utilization patterns of low-titer group O whole blood in a level 1 trauma center.

Transfusion·2026

Emergency whole-tank transfer of cord blood units after cryogenic failure: A safe rescue strategy.

Transfusion·2026

Comparative analysis of motixafortide versus plerixafor for stem cell mobilization and collection in multiple myeloma: A single center real-world experience.

Transfusion·2026

Postpartum-onset anti-PM/Scl-positive dermatomyositis-systemic sclerosis overlap syndrome with reversible interstitial lung disease: a case report.

Frontiers in medicine·2026

Severe recurrent anaphylaxis: investigating underlying mechanisms beyond IgE-mediated allergy - a case report.

Frontiers in allergy·2026

Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.

Frontiers in immunology·2026

Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).

Frontiers in immunology·2026

Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis: a single-center retrospective study.

Frontiers in immunology·2026

Successful management of pembrolizumab-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with uterine serous carcinoma: a case report.

Frontiers in immunology·2026

Related Experiment Videos

EDTA-saline and ABO system antibodies

Related Concept Videos

Reactivity of FDA-approved anti-D reagents with partial D red blood cells.

On a much higher than reported incidence of anti-c in R1R1 patients with anti-E.

The gel test: use in the identification of unexpected antibodies to blood group antigens.

PEG adsorption of autoantibodies causes loss of concomitant alloantibody.

Molecular defects underlying the Kell null phenotype.

The first example of a paraben-dependent antibody to an Rh protein.

Confirmatory testing of military blood donors screening positive for Babesia infection.

A global survey of blood transfusion practices for patients with sickle cell disease.

Normal thromboelastography with a markedly prolonged activated partial thromboplastin time in severe prekallikrein deficiency: Implications for perioperative hemostatic assessment.

Utilization patterns of low-titer group O whole blood in a level 1 trauma center.

Emergency whole-tank transfer of cord blood units after cryogenic failure: A safe rescue strategy.

Comparative analysis of motixafortide versus plerixafor for stem cell mobilization and collection in multiple myeloma: A single center real-world experience.

Postpartum-onset anti-PM/Scl-positive dermatomyositis-systemic sclerosis overlap syndrome with reversible interstitial lung disease: a case report.

Severe recurrent anaphylaxis: investigating underlying mechanisms beyond IgE-mediated allergy - a case report.

Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.

Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).

Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis: a single-center retrospective study.

Successful management of pembrolizumab-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with uterine serous carcinoma: a case report.

Related Experiment Videos

EDTA-saline and ABO system antibodies

Related Concept Videos

Related Articles